China cannot win the great vaccine diplomacy game without vaccines
A few reasons why China’s vaccine diplomacy, which has been successful so far, may get into difficulties: – China needs to produce large quantities of the vaccine in order to vaccinate the planned 40% of its population by the end of June. This fact will reduce the number of vaccines China can share with others. – There are doubts about the efficiency of the Chinese vaccines when it comes to the new Coronavirus variants. China’s fast and efficient start of vaccine diplomacy may see setbacks in the coming months, as its competitors, especially the USA, will have more capacities to share vaccines with the rest of the world.
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.